Risk Factors and Predictive Model for Dermatomyositis Associated with Rapidly Progressive Interstitial Lung Disease

被引:9
作者
Wang, Kai [1 ]
Tian, Yian [1 ]
Liu, Shanshan [1 ]
Zhang, Zhongyuan [1 ]
Shen, Leilei [1 ]
Meng, Deqian [1 ]
Li, Ju [1 ]
机构
[1] Nanjing Med Univ, Dept Rheumatol, Affiliated Huaian 1 Peoples Hosp, Huaian 223001, Peoples R China
关键词
dermatomyositis; interstitial lung disease; risk factor; predictive model; logistic regression; least absolute shrinkage and selection operator; random forest; extreme gradient boosting; GENE; 5; ANTIBODY; AUTOANTIBODIES; REGRESSION; PROGNOSIS; PROFILES; MYOSITIS; FEATURES;
D O I
10.2147/PGPM.S369556
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Rapidly progressive interstitial lung disease (RP-ILD) is a significant complication that determines the prognosis of dermatomyositis (DM). Early RP-ILD diagnosis can improve screening and diagnostic efficiency and provide meaningful guidance to carry out early and aggressive treatment.Methods: A retrospective screening of 284 patients with DM was performed. Clinical and laboratory characteristics of the patients were recorded. The risk factors of RP-ILD in DM patients were screened by logistic regression (LR) and machine learning methods, and the prediction models of RP-ILD were developed by machine learning methods, namely least absolute shrinkage and selection operator (LASSO), random forest (RF), and extreme gradient boosting (XGBoost).Results: According to the result of univariate LR, disease duration is a protective factor for RP-ILD, and ESR, CRP, anti-Ro-52 antibody and anti-MDA5 antibody are risk factors for RP-ILD. The top 10 important variables of the 3 machine learning models were intersected to obtain common important variables, and there were 5 common important variables, namely disease duration, LDH, CRP, anti-Ro-52 antibody and anti-MDA5 antibody. The AUC of LASSO, RF and XGBoost test set were 0.661, 0.667 and 0.867, respectively. We further validated the performance of these three models on validation set, and the results showed that, the AUC of LASSO, RF and XGBoost were 0.764, 0.727 and 0.909, respectively. Based on the results of the models, XGBoost is the optimal model in this study.Conclusion: Disease duration, LDH, CRP, anti-Ro-52 antibody and anti-MDA5 antibody are vital risk factors for RP-ILD in DM. The prediction model constructed using XGBoost can be used for risk identification and early intervention in DM patients with RP-ILD and practical application.
引用
收藏
页码:775 / 783
页数:9
相关论文
共 41 条
[1]   Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjogren syndrome [J].
Buvry, Charlotte ;
Cassagnes, Lucie ;
Tekath, Marielle ;
Artigues, Maxime ;
Pereira, Bruno ;
Rieu, Virginie ;
Le Guenno, Guillaume ;
Tournadre, Anne ;
Ruivard, Marc ;
Grobost, Vincent .
RESPIRATORY MEDICINE, 2020, 163
[2]   A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy [J].
Cadrin-Tourigny, Julia ;
Bosman, Laurens P. ;
Nozza, Anna ;
Wang, Weijia ;
Tadros, Rafik ;
Bhonsale, Aditya ;
Bourfiss, Mimount ;
Fortier, Annik ;
Lie, Oyvind H. ;
Saguner, Ardan M. ;
Svensson, Anneli ;
Andorin, Antoine ;
Tichnell, Crystal ;
Murray, Brittney ;
Zeppenfeld, Katja ;
van den Berg, Maarten P. ;
Asselbergs, Folkert W. ;
Wilde, Arthur A. M. ;
Krahn, Andrew D. ;
Talajic, Mario ;
Rivard, Lena ;
Chelko, Stephen ;
Zimmerman, Stefan L. ;
Kamel, Ihab R. ;
Crosson, Jane E. ;
Judge, Daniel P. ;
Yap, Sing-Chien ;
van der Heijden, Jeroen F. ;
Tandri, Harikrishna ;
Jongbloed, Jan D. H. ;
Guertin, Marie-Claude ;
van Tintelen, J. Peter ;
Platonov, Pyotr G. ;
Duru, Firat ;
Haugaa, Kristina H. ;
Khairy, Paul ;
Hauer, Richard N. W. ;
Calkins, Hugh ;
te Riele, Anneline S. J. M. ;
James, Cynthia A. .
EUROPEAN HEART JOURNAL, 2019, 40 (23) :1850-1858
[3]   XGBoost: A Scalable Tree Boosting System [J].
Chen, Tianqi ;
Guestrin, Carlos .
KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, 2016, :785-794
[4]   Logistic regression model to predict acute uncomplicated and complicated appendicitis [J].
Eddama, M. M. R. ;
Fragkos, K. C. ;
Renshaw, S. ;
Aldridge, M. ;
Bough, G. ;
Bonthala, L. ;
Wang, A. ;
Cohen, R. .
ANNALS OF THE ROYAL COLLEGE OF SURGEONS OF ENGLAND, 2019, 101 (02) :107-118
[5]   Regularization Paths for Generalized Linear Models via Coordinate Descent [J].
Friedman, Jerome ;
Hastie, Trevor ;
Tibshirani, Rob .
JOURNAL OF STATISTICAL SOFTWARE, 2010, 33 (01) :1-22
[6]   Cytokine profiles in polymyositis and dermatomyositis complicated by rapidly progressive or chronic interstitial lung disease [J].
Gono, Takahisa ;
Kaneko, Hirotaka ;
Kawaguchi, Yasushi ;
Hanaoka, Masanori ;
Kataoka, Sayuri ;
Kuwana, Masataka ;
Takagi, Kae ;
Ichida, Hisae ;
Katsumata, Yasuhiro ;
Ota, Yuko ;
Kawasumi, Hidenaga ;
Yamanaka, Hisashi .
RHEUMATOLOGY, 2014, 53 (12) :2196-2203
[7]  
Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO
[8]  
2-4
[9]   Relevance of interferon-gamma in pathogenesis of life-threatening rapidly progressive interstitial lung disease in patients with dermatomyositis [J].
Ishikawa, Yuichi ;
Iwata, Shigeru ;
Hanami, Kentaro ;
Nawata, Aya ;
Zhang, Mingzeng ;
Yamagata, Kaoru ;
Hirata, Shintaro ;
Sakata, Kei ;
Todoroki, Yasuyuki ;
Nakano, Kazuhisa ;
Nakayamada, Shingo ;
Satoh, Minoru ;
Tanaka, Yoshiya .
ARTHRITIS RESEARCH & THERAPY, 2018, 20
[10]   Recognition and Management of Myositis-Associated Rapidly Progressive Interstitial Lung Disease [J].
Jablonski, Renea ;
Bhorade, Sangeeta ;
Strek, Mary E. ;
Dematte, Jane .
CHEST, 2020, 158 (01) :252-263